16462-29-6 Usage
General Description
4-Amino-2-ethylsulfanyl-pyrimidine-5-carbonitrile is a chemical compound with the molecular formula C7H9N5S. It is a pyrimidine derivative and contains an amino group, an ethylsulfanyl group, and a carbonitrile group. 4-AMINO-2-ETHYLSULFANYL-PYRIMIDINE-5-CARBONITRILE has potential applications in pharmaceutical research and development, particularly in the synthesis of new drugs and pharmaceutical products. Its unique structure and properties make it a valuable building block for the creation of various biologically active compounds. It may also have potential uses in the field of agrochemicals and materials science. Overall, 4-Amino-2-ethylsulfanyl-pyrimidine-5-carbonitrile is a versatile and important chemical with diverse potential applications in various scientific and industrial fields.
Check Digit Verification of cas no
The CAS Registry Mumber 16462-29-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,4,6 and 2 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 16462-29:
(7*1)+(6*6)+(5*4)+(4*6)+(3*2)+(2*2)+(1*9)=106
106 % 10 = 6
So 16462-29-6 is a valid CAS Registry Number.
InChI:InChI=1/C7H8N4S/c1-2-12-7-10-4-5(3-8)6(9)11-7/h4H,2H2,1H3,(H2,9,10,11)
16462-29-6Relevant articles and documents
Synthesis and anticancer activity of novel 2-alkylthio-4-amino-5-(thiazol-2-YL)pyrimidines
Bunev, Alexander S.,Khochenkov, Dmitry A.,Khochenkova, Yulia A.,Machkova, Yulia S.,Varakina, Elena V.,Gasanov, Rovshan E.,Troshina, Marina A.,Avdyakova, Olga S.
supporting information, p. 2521 - 2527 (2021/06/25)
A series of new fist-time synthesized of thiazolyl-substituted 4-aminopyrimidine was obtained on the basis of a two-stage process including thioamidation of 4-amino-5-cyanopyrimide followed by one-pot acylation and Hantzsch synthesis in good yield (52–77%
ANTI-VIRAL COMPOUNDS
-
Page/Page column 115, (2008/12/08)
Compounds effective in inhibiting replication of Hepatitis C virus ( HCV ) or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, coformulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.